Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|MP0317||MP-0317|MP 0317||MP0317 consists of a CD40 agonist cross-linked to fibroblast activation protein (FAP), which may activates anti-tumor immunity within tumor microenvironment (Cancer Res 2020;80(16 Suppl):Abstract nr 1073).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT05098405||Phase I||MP0317||First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors||Recruiting||FRA||1|